Northern Trust’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.54M Buy
436,947
+57,072
+15% +$854K ﹤0.01% 2316
2025
Q1
$6.13M Buy
379,875
+30,892
+9% +$498K ﹤0.01% 2313
2024
Q4
$8.12M Buy
348,983
+34,693
+11% +$808K ﹤0.01% 2240
2024
Q3
$9.24M Buy
314,290
+228,702
+267% +$6.73M ﹤0.01% 2110
2024
Q2
$2.01M Buy
85,588
+19,248
+29% +$453K ﹤0.01% 2896
2024
Q1
$2.52M Buy
+66,340
New +$2.52M ﹤0.01% 2848
2023
Q3
Sell
-3,917
Closed -$44.1K 4523
2023
Q2
$44.1K Hold
3,917
﹤0.01% 4246
2023
Q1
$28.4K Buy
3,917
+460
+13% +$3.34K ﹤0.01% 4379
2022
Q4
$38.9K Buy
3,457
+689
+25% +$7.75K ﹤0.01% 4343
2022
Q3
$36K Hold
2,768
﹤0.01% 4413
2022
Q2
$35K Sell
2,768
-10,582
-79% -$134K ﹤0.01% 4511
2022
Q1
$768K Sell
13,350
-638
-5% -$36.7K ﹤0.01% 3551
2021
Q4
$1.66M Sell
13,988
-640
-4% -$76K ﹤0.01% 3316
2021
Q3
$2.91M Sell
14,628
-106
-0.7% -$21.1K ﹤0.01% 3075
2021
Q2
$2.56M Sell
14,734
-3,319
-18% -$578K ﹤0.01% 3239
2021
Q1
$3.57M Sell
18,053
-1,170
-6% -$232K ﹤0.01% 2949
2020
Q4
$3.78M Buy
19,223
+357
+2% +$70.2K ﹤0.01% 2839
2020
Q3
$3.35M Sell
18,866
-1,091
-5% -$193K ﹤0.01% 2772
2020
Q2
$4.62M Buy
19,957
+8,106
+68% +$1.87M ﹤0.01% 2573
2020
Q1
$1.38M Buy
11,851
+102
+0.9% +$11.9K ﹤0.01% 3057
2019
Q4
$2.24M Sell
11,749
-340
-3% -$64.9K ﹤0.01% 3054
2019
Q3
$2.32M Buy
12,089
+2,704
+29% +$520K ﹤0.01% 3017
2019
Q2
$1.61M Buy
9,385
+747
+9% +$128K ﹤0.01% 3177
2019
Q1
$1.74M Buy
8,638
+1,328
+18% +$267K ﹤0.01% 3160
2018
Q4
$1.37M Buy
7,310
+37
+0.5% +$6.93K ﹤0.01% 3251
2018
Q3
$1.74M Buy
7,273
+186
+3% +$44.5K ﹤0.01% 3279
2018
Q2
$1.87M Buy
7,087
+6,356
+869% +$1.68M ﹤0.01% 3235
2018
Q1
$181K Buy
731
+71
+11% +$17.6K ﹤0.01% 3848
2017
Q4
$89K Hold
660
﹤0.01% 3994
2017
Q3
$81K Hold
660
﹤0.01% 3996
2017
Q2
$64K Hold
660
﹤0.01% 4048
2017
Q1
$123K Buy
+660
New +$123K ﹤0.01% 3912